Skip to main content
logo
The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.3950
-0.0250 (-5.95%)
At close: Mar 20, 2026

CSE:BPC Revenue

In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K CAD with 307.47% growth. The Precision Peptide Company had revenue of 43.80K in the quarter ending October 31, 2025, with 3,955.93% growth.

Revenue
49.72K
Revenue Growth
+307.47%
P/S Ratio
340.52
Revenue / Employee
n/a
Employees
2
Market Cap
16.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Oct 31, 202549.72K37.52K307.47%
Oct 31, 202412.20K-273.39K-95.73%
Oct 31, 2023285.59K-295.40K-50.84%
Oct 31, 2022580.99K463.57K394.79%
Oct 31, 2021117.42K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

The Precision Peptide Company News

More News